List of pharmaceutical companies
The following is a list of the twelve largest health care companies ranked here by revenue as of March 2010[update] according to their released 2009 annual reports.
Rank | Company | Country | Total Revenues (USD billions) | Total Revenues (reported currency in millions) | Change 09/08 (%) | Net income/ (loss) (reported currency in millions) | Change 09/08 (%) | R&D Expenses (reported currency in millions) | Change 09/08 (%) | Fortune 500 Ranking[1] |
---|---|---|---|---|---|---|---|---|---|---|
1 | Johnson & Johnson[2] | United States | 61.90[3] | $61,897 | -2.9 | $12,266 | -5.3 | 6,986 | -7.8 | 103 |
2 | Pfizer[4] | United States | 50.01[3] | $50,009 | 3.5 | 8,635 | 6.6 | 7,845 | -1.3 | 152 |
3 | Roche[5] | Switzerland | 47.35[3] | 49,051 CHF | 7.5 | 8,510 CHF | -21.5 | 9,874 CHF | 11.6 | 171 |
4 | GlaxoSmithKline[6] | United Kingdom | 45.83[3] | £28,368 | 16.5 | £5,669 | 20.3 | £4,106 | 11.5 | 168 |
5 | Novartis[7] | Switzerland | 44.27[3] | $44,267 | 6.8 | $8,454 | 3.6 | $7,469 | 3.5 | 183 |
6 | Sanofi[8] | France | 41.99[3] | €29,306 | 6.3 | €8,471 | 17.9 | €4,583 | 0.2 | 181 |
7 | AstraZeneca[9] | UK/Sweden | 32.81[10] | $32,804 | 3.8 | $7,544 | 23.1 | $4,409 | -14.9 | 268 |
8 | Abbott Laboratories[11] | United States | 30.76[10] | $30,765 | 4.2 | 5,746 | 21.4 | 2,744 | 2.1 | 294 |
9 | Merck & Co.[12] | United States | 27.43[10] | $27,428 | 15.0 | $13,024 | 64.2 | $5,800 | 20.8 | 378 |
10 | Bayer HealthCare[13] | Germany | 22.30 | €15,988 | 3.8 | €1,696 | 38.8 | €1,845 | 5.9 | 154 |
11 | Eli Lilly[14] | United States | 21.84[15] | $21,836 | 7.2 | $4,328 | N/A | N/A | N/A | 455 |
12 | Bristol-Myers Squibb[16] | United States | 18.81[17] | $18,808 | 6.2 | $4,420 | 19.9 | 3,647 | 3.8 | 435 |
Some data have not been audited yet. Bayer has additional revenue not included here. The missing parts of the table will be added as more data are released by the companies.
The following is a list of the twelve largest healthcare companies ranked by revenue as of July 2009[update] in the Fortune Global 500.[1]
Rank[1] | Company | Country | Total Revenues (USD millions) | Net income/ (loss) (USD millions) | Employees |
---|---|---|---|---|---|
1 | Johnson & Johnson | United States | 63,747.0[18] | 12,949.0 | 118,700 |
2 | Pfizer | United States | 48,296.0[19] | 8,104.0 | 81,800 |
3 | GlaxoSmithKline | United Kingdom | 44,654.0[20] | 8,438.6 | 99,003 |
4 | Roche | Switzerland | 44,267.5[21] | 8,288.1 | 80,080 |
5 | Sanofi-Aventis | France | 42,179.0[22] | 5,636.7 | 98,213 |
6 | Novartis | Switzerland | 41,459.0[23] | 8,195.0 | 96,717 |
7 | AstraZeneca | United Kingdom/Sweden | 31,601.0[24] | 6,101.0 | 65,000 |
8 | Abbott Laboratories | United States | 29,527.6[25] | 4,880.7 | 68,838 |
9 | Merck | United States | 23,850.3[26] | 7,808.4 | 55,200 |
10 | Wyeth | United States | 22,833.9[27] | 4,417.8 | 47,426 |
11 | Bristol-Myers Squibb | United States | 21,366.0[28] | 5,247.0 | 35,000 |
12 | Eli Lilly | United States | 20,378.0[29] | (2,071.9) | 40,500 |
The following is a list of the 49 largest companies involved in pharmaceutical and biotech industry ranked by healthcare revenue as of 2008[update].[30] Some companies (e.g., Bayer) has additional revenue not included here.[31][32]
Rank[30] | Company | Country | Total Revenues (USD millions) | Healthcare R&D 2008 (USD millions) | Net income/ (loss) 2008 (USD millions) | Employees 2008 |
---|---|---|---|---|---|---|
1 | Pfizer[33] (with Wyeth[34]) | United States | 70,696 | 11,318 | 14,111 | 137,127 |
2 | Johnson & Johnson | United States | 63,747 | NA | 10,576 | 119,200 |
3 | Hoffmann–La Roche | Switzerland | 43,970 | NA | 8,135 | 78,604 |
4 | Novartis | Switzerland | 41,460 | NA | 11,946 | 98,200 |
5 | GlaxoSmithKline | United Kingdom | 40,424 | 6,373 | 10,432 | 103,483 |
6 | Sanofi-Aventis | France | 40,328 | NA | 7,204 | 99,495 |
7 | AstraZeneca | United Kingdom/Sweden | 31,601 | NA | 5,959 | 67,400 |
8 | Abbott Laboratories[35] | United States | 29,527 | 2,688 | 4,880 | 68,697 |
9 | Merck & Co. | United States | 23,850 | 4,678 | 7,808 | 74,372 |
10 | Bristol-Myers Squibb | United States | 19,977 | NA | 2,165 | 42,000 |
11 | Eli Lilly and Company | United States | 18,634 | NA | 2,953 | 40,600 |
12 | Boehringer Ingelheim | Germany | 16,959 | 1,977 | 2,163 | 43,000 |
13 | Takeda Pharmaceutical Co. | Japan | 15,697 | 1,620 | 2,870 | 15,000 |
14 | Bayer [36] | Germany | 15,407 | 3,770 | 6,448 | 108,600 |
15 | Amgen | United States | 14,771 | 3,366 | 3,166 | 48,000 |
16 | Genentech | United States | 13,400 | 15773 | 3,640 | 33,500 |
17 | Baxter International | United States | 12,300 | 614 | 1,397 | 38,428 |
18 | Teva Pharmaceutical Industries | Israel | 11,080 | 495 | 546 | 26,670 |
19 | Astellas Pharma | Japan | 10,701 | 1,435 | 1,122 | 23,613 |
20 | Daiichi Sankyo | Japan | 9,682 | 1,459 | 671 | 20,100 |
21 | Novo Nordisk | Denmark | 9,081 | 1,063 | 1,922 | 26,575 |
22 | Procter & Gamble | United States | 8,964 | NA | 10,340 | 29,258 |
23 | Eisai | Japan | 5,583 | 926 | 604 | 14,993 |
24 | Merck KGaA | Germany | 5,175 | 772 | 1,258 | 13,900 |
25 | Alcon | United States | 4,897 | 512 | 1,348 | 13,500 |
26 | SINOPHARM | China | 4,700 | 498 | 1249 | 9700 |
27 | Akzo Nobel | Netherlands | 4,694 | 741 | 1,449 | 13,000 |
28 | UCB | Belgium | 4,426 | 1,024 | 492 | 12,741 |
29 | Nycomed | Switzerland | 4,264 | NA | -105 | 10,533 |
30 | Forest Laboratories | United States | 3,442 | 941 | 454 | 9,649 |
31 | Solvay | Belgium | 3,268 | 533 | 1,026 | 9,000 |
32 | Genzyme | United States | 3,187 | 650 | -17 | 8,477 |
33 | Allergan | United States | 3,063 | 1,056 | -127 | 8,423 |
34 | Gilead Sciences | United States | 3,026 | 384 | -1,190 | 6,772 |
35 | CSL | Australia | 2,788 | 161 | 454 | 6,400 |
36 | Chugai Pharmaceutical Co. | Japan | 2,787 | 467 | 328 | 5,962 |
37 | Biogen Idec | United States | 2,683 | 718 | 218 | 5,907 |
38 | Bausch & Lomb | United States | 2,292 | 197 | 15 | 5,830 |
39 | Taiho Pharmaceutical Co. | Japan | 2,069 | 244 | 132 | 5,756 |
40 | King Pharmaceuticals | United States | 1,989 | 254 | 289 | 5,191 |
41 | Watson Pharmaceuticals | United States | 1,979 | 131 | -445 | 5,126 |
42 | Mitsubishi Pharma | Japan | 1,945 | 403 | 208 | 5,111 |
43 | Shire | United Kingdom | 1,797 | 387 | 278 | 4,958 |
44 | Cephalon | United States | 1,764 | 403 | 145 | 4,913 |
45 | Dainippon Sumitomo Pharma | Japan | 1,763 | 350 | 193 | 3,750 |
46 | Kyowa Hakko | Japan | 1,698 | 268 | 108 | 2,895 |
47 | Shionogi | Japan | 1,640 | 320 | 159 | 2,868 |
48 | Mylan Laboratories | United States | 1,612 | 104 | 217 | 2,800 |
49 | H. Lundbeck | Denmark | 1,552 | 329 | 186 | 2,515 |
Alphabetical listing
It is limited to those companies notable enough to have articles in Wikipedia.
1-A
- 3M Pharmaceuticals
- Abbott Laboratories
- Actavis
- Actelion
- Advaxis
- Alcon
- Alexion Pharmaceuticals
- Alkaloid
- Alkermes
- Allergan
- Almirall
- Alphapharm
- Altana Pharma AG
- Amgen
- Amico Laboratories
- Anavex Life Sciences
- Apotex Inc.
- Astellas Pharma
- AstraZeneca
- Avax Technologies
- Axcan Pharma
- Ajanta Pharma
B-D
- Bargn Farmaceutici Phils Co
- Barr
- Bausch & Lomb
- Baxter International
- Bayer Schering Pharma AG
- Beximco Pharmaceuticals Ltd
- Bial
- Biocon
- Biogen Idec
- Biolex
- Bionovo
- Biotecnol
- Biovail
- Biovitrum
- Boehringer-Ingelheim
- Bosnalijek
- Bristol-Myers Squibb
- Beximco Pharma
- Cadila Healthcare
- Celgene
- Centaur
- Cephalon
- Chugai Pharmaceutical Co.
- CinnaGen
- Cipla
- Covance
- Covidien
- Crucell
- CSL Limited
- Daiichi Sankyo
- Dainippon Sumitomo Pharma
- Dawakhana Shifaul Amraz
- Debiopharm
- Diabetology Ltd
- Diffusion Pharmaceuticals
- Dr. Reddy's Laboratories
E-L
- Ego Pharmaceuticals
- Eisai (company)
- Élan Corporation
- Eli Lilly and Company
- Elorac, Inc.
- Emergent BioSolutions
- Elder Pharmaceuticals
- Endo Pharmaceuticals
- Eskayef Bangladesh Limited
- F. Hoffmann–La Roche Ltd., which owns Genentech and Chugai Pharmaceuticals
- Ferring Pharmaceuticals
- Forest Laboratories
- Fresenius Medical Care
- Galapagos NV
- Galderma Laboratories
- Genentech, a subsidiary of Hoffmann-La Roche
- Genzyme
- Getz Pharma
- Gilead Sciences
- GlaxoSmithKline
- Glenmark Pharmaceuticals
- GPC Biotech
- Gulf Pharmaceutical Industries (Julphar)
- Help Remedies
- Helsinn
- Hetero Drugs
- Hexal Australia
- Hikma Pharmaceuticals
- Hoffmann–La Roche
- Hospira
- IMULAN BioTherapeutics, LLC
- Institute for OneWorld Health
- Intas Biopharmaceuticals
- Intercytex
- Interphil Laboratories
- Incepta Pharmaceuticals
- Janssen Pharmaceutica Products, a subsidiary of Johnson & Johnson
- Jenapharm, a subsidiary of Bayer Schering Pharma
- JN-International Medical Corporation
- Johnson & Johnson
- Lupin Limited
M
- MannKind Corporation
- McGuff
- Melior Discovery
- Menarini
- Merck & Co.
- Merck KGaA
- Millennium Pharmaceuticals
- Mitsubishi Pharma
- Mylan
N
O
- Octapharma
- Orion Pharma
- Ortho-McNeil Pharmaceutical, a subsidiary of Johnson & Johnson
- Otsuka Pharmaceutical Co.
- Orexo
P
- Panacea Biotec Ltd
- Patheon
- Par Pharmaceutical
- Perrigo
- Pfizer
- Pharmacosmos
- Pharma Nord
- Pierre Fabre Group
- Piramal Healthcare
- Pliva
- Procter & Gamble
- Purdue Pharma
R
- Ranbaxy Laboratories, generics arm of Daiichi Sankyo
- Renovo
- Respa Pharmaceuticals
- Gedeon Richter Ltd.
- Rubicon Research
S-T
- Salix Pharmaceuticals
- Sanofi-Aventis
- Square Pharmaceuticals
- Schering-Plough
- Sepracor
- Servier Laboratories
- Serum Institute of India
- Shionogi
- Shire plc
- Sigma Pharmaceuticals
- Sinopharm Group
- Solvay Group
- STADA Arzneimittel
- Strides Arcolab
- Sun Pharmaceutical
- Square Pharmaceuticals
- Teva Pharmaceuticals
- Torrent Pharmaceuticals
U-Z
- UCB
- UNILAB, also known as United Laboratories
- Valeant Pharmaceuticals International, formerly ICN Pharmaceuticals.
- Veloxis Pharmaceuticals
- Vertex Pharmaceuticals
- Vion Pharmaceuticals, Inc.
- ViroPharma
- Von Melk Pharmaceuticals
- Wallace Pharmaceuticals
- Warner Chilcott
- Wockhardt
- Wyeth, a subsidiary of Pfizer
- Zandu Pharmaceuticals
- Zentiva
See also
References
- ^ a b c
"Fortune Global 500 2009 Pharmaceutical Industry". Fortune. 160 (2). 2009. Retrieved 2009-12-18.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ "Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results". 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ a b c d e f "The Global 2000". 2010. Retrieved 2010-08-15.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "2009 Pfizer Financial Report". 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "09 Roche in Brief" (PDF). 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Annual Reports". 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Annual Report 2009". 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Annual Results 2009". 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Condensed Consolidated Statement of Comprehensive Income" (PDF). 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ a b c "The Global 2000". 2010. Retrieved 2010-08-15.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Annual Report 2009". 2010. Retrieved 2010-04-29.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Merck Announces Fourth-Quarter and Full-Year 2009 Financial Results". Merck & Co. 2009-07-20. Retrieved 2010-02-12.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Annual Report 009". 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Lilly Reports Fourth-Quarter and Full-Year 2009 Results". 2010. Retrieved 2010-03-02.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "The Global 2000". 2010. Retrieved 2010-08-15.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "2009 Annual Report" (PDF). 2010. Retrieved 2010-04-29.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "The Global 2000". 2010. Retrieved 2010-08-15.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Johnson & Johnson - JNJ". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Pfizer - PFE". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "GlaxoSmithKline - GSK". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Roche Group - RHHVF". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Sanofi-Aventis - SNY". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Novartis - NVS". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "AstraZeneca - AZN". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Abbott Laboratories - ABT". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Merck - MRK". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Wyeth - WYE". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Bristol-Myers Squibb - BMY". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ "Eli Lilly - LLY". Fortune. 2009-07-20. Retrieved 2010-02-12.
- ^ a b "Global 500". CNN. 2008. Retrieved 2009-07-27.
- ^ "Company Structure". 2009. Retrieved 2010-03-03.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Profile and Organization". 2010-01-01. Retrieved 2010-03-03.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Pfizer Annual Report" (PDF). 2008. Retrieved 2009-07-24.
- ^ "Wyeth Annual Report" (PDF). 2008. Retrieved 2009-07-24.
- ^ "Abbott Annual Report" (PDF). 2008. Retrieved 2009-07-24.
- ^ "Kennzahlen Bayer Konzern". 2008. Retrieved 2009-07-27.